ISFA-E-ISFA 2021
Evidencia científica
S-05-06 Efficacy of Adsorptive Granulocyte/Monocyte Apheresis in Inflammatory Bowel Disease Patients Experiencing Loss of Response to Infliximab (poster)
To our knowledge this is the first report of adding GMA to restore the efficacy of infliximab in patients with LoR. However, the efficacy outcomes following addition of a non-drug GMA to infliximab is potentially very interesting in therapeutic settings and should inspire further studies
combination / Crohn's disease / efficacy / gastroenterology / gma / IBD / Infliximab / Loss of response / ulcerative colitis /
ContáctanosPara solicitar información adicional
Contáctanos